
RSC Advances p. 57414 - 57424 (2015)
Update date:2022-08-11
Topics:
Wang, Xue
Zhao, Ke-Qing
Elsegood, Mark R. J.
Prior, Timothy J.
Liu, Xiaoming
Wu, Li
Sanz, Sergio
Brechin, Euan K.
Redshaw, Carl
Complexes of the type [Cu(L)2] (1) and [Cu4L2(μ4-O)(OAc)4] (2) have been obtained from the reaction of the phenoxydiimine 1,3-(2,6-R22C6H3NCH)2-5-R1C6H2OH-2 (LH) (where R1 = Me, tBu, Cl; R2 = Me, iPr) with copper(ii) acetate [Cu(OAc)2]; changing the molar ratio of the reactants affords differing amounts of 1 or 2. Reaction of the parent dialdehyde [1,3-(CHO)2-5-MeC6H2OH-2] with [Cu(OAc)2] in the presence of Et3N afforded, following work-up, a polymeric chain (3) comprising {[Cu2(OAc)4]OAc}n, HNEt3 and MeCN. The crystal structures of 1 (R1 = Me, R2 = iPr 1a; R1 = Cl, R2 = iPr 1b), 2 (R1 = Me, R2 = Me 2a; R1 = Me, R2 = iPr 2b; R1 = tBu, R2 = Me 2c; R1 = Cl, R2 = Me 2d; R1 = Cl, R2 = iPr 2e; R1 = tBu, R2 = iPr 2f) and 3 are reported (synchrotron radiation was necessary for 3). The magnetic properties of the cluster 2b are presented. Complexes of type 2 and 3 were screened for the ring opening polymerization (ROP) of ε-caprolactone, with or without benzyl alcohol present, under a variety of conditions, however only trace polymer was isolated. The electrochemistry of all complexes was also investigated, together with their ability to catalyze benzene oxidation (using hydrogen peroxide); although low conversions were observed, the tetra-nuclear complexes exhibited excellent selectivity.
View More
website:http://www.lidepharma.com
Contact:+86-25-58409506
Address:Chungking Express Nos.36 Nathan Road,Kowloon, HK
Sanming Coffer Fine Chemical Industrial Co., Ltd
website:http://www.cofferxm.com/
Contact:+86-598-5853979
Address:Jin-sha Yuan Chuang-ye Park,Hi-Tech Development Zone,Sanming City P.R.China
shijiazhuang shuanglian chemical industry co.,ltd
Contact:0311-82190302
Address:Luquan Intersection , Shijiazhuang--Taiyuan Expressway,Shijiazhuang City
Contact:86-21-34622192,13917187091,21-34622765
Address:No. 500 Caobao Road Shanghai P.R China
Shanghai Xinda Pharmaceuticals Co., Ltd.
Contact:86-21-33692333-8008
Address:999 Linxian Road, Jinshan Industrial Park, Shanghai, China
Doi:10.1021/ja01558a027
(1957)Doi:10.1021/ol036065z
(2004)Doi:10.1149/1.2799048
(2008)Doi:10.1039/d1ta00031d
(2021)Doi:10.1080/24701556.2020.1724147
(2020)Doi:10.1002/adsc.200900281
(2009)